Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Hot Flashes 5Breast Neoplasms 4Prostatic Neoplasms 2Head and Neck Neoplasms 2Depression 2Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Sleep Wake Disorders 1Lymphoma, Follicular 1Depressive Disorder, Major 1Depressive Disorder 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Bipolar Disorder 1

Interventions

Therapeutics 28Psychiatric Rehabilitation 21Surveys and Questionnaires 14Cognitive Behavioral Therapy 12Psilocybin 8Methods 8Ketamine 8Early Intervention, Educational 8Saline Solution 7Yoga 6Mindfulness-Based Cognitive Therapy 6Interviews as Topic 6Esketamine 6Psychosocial Intervention 5Mindfulness 5Escitalopram 5Behavior Therapy 5Methylphenidate 4Exercise Therapy 4Exercise 4Educational Status 4Counseling 4Control Groups 4Acupuncture Therapy 4Standard of Care 3Psychotherapy 3Palliative Care 3Niacin 3Mindfulness-Based Stress Reduction 3Melatonin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Depression × Venlafaxine Hydrochloride × Clear all
NCT00667121 2025-02-14

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Mayo Clinic

Completed
88 enrolled
Breast

Breast Neoplasms, Depression, Hot Flashes

NCT05724849 2024-01-18

Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer

Vanderbilt University Medical Center

Phase 2 Withdrawn
Head & Neck

Depression, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡